Skip to search formSkip to main contentSkip to account menu

Peru 15

Known as: Peru-15 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Cholera Vaccine
CholeraGarde

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
The state-of-the-art of approved and under-development cholera vaccines.
2007
2007
Gateways to clinical trials.
1E10, 101M; AAV-ASPA, agomelatine, aliskiren fumarate, alvimopan hydrate, ambrisentan, apaziquone, axitinib; Becatecarin… 
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials reported in current literature and congresses. The data… 
Review
2004
Review
2004
Peru-1 5 (AVANT).
Peru-15 is a single dose, recombinant cholera vaccine under development by AVANT Immunotherapeutics for the potential prevention… 
1998
1998
Replicating function of the RS1 element associated with Vibrio cholerae CTX phi prophage.
The RS1 element associated with Vibrio cholerae CTX phi prophage was cloned from an E1 Tor biotype Vibrio cholerae strain. We… 
1997
1997
Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers
During development of Peru-15, a new live oral vaccine for cholera, the role of buffer needed to be evaluated. Generally, oral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)